By Svea Herbst-Bayliss
New York (Reuters) -Millionaire investor Daniel Loeb’s Hedgefonds Third Point builds an interest in Kenvue, sources that are familiar with the case that are said on Friday, because some investors insist on strategic changes at the Consumer Health Care Company.
News about the investment of Third Point in the top of $ 44 billion, New Jersey headquarters of Band-AIDS and Tylenol helped to increase his share price in the late afternoon trade on Friday before he gives up some profits to close to $ 23.01.
Kenvue, spun from Johnson & Johnson two years ago, has been dealing with pressure from activist investors for months and avoided a completely blown proxy fight with starboard value in March when it added the founder and chief executive of the company, Jeffrey Smith, to his administration.
Starboard pressed the company to assess how it positions its brands and how they are priced to stimulate his performance.
Since reaching his agreement with starboard, Kenvue has confronted with pressure from Toms Capital Investment Management, another activist company that has also built up an interest and wants the company to consider strategic alternatives, including a possible sale of the entire company or parts of it, according to sources that are familiar with the company’s engagement.
It could not be determined how great the investment of Third Point is or whether the hedge fund is involved with the board or management of Kenvue. A representative for the third point refused to comment. The Financial Times reported the importance of Third Point in Kenvue on Friday.
Kenvue said that it regularly deals with his investors, but does not comment on individual investor discussions. The board acts “in the best interest of the company and all shareholders of Kenvue and we remain aimed at accelerating sustainable, profitable growth and improving shareholders’ value,” the company said in a statement.
While the Kenvue brands, including Aveeno, Listerine and Zyrtec, are known, the net turnover in 2024 were flat at $ 15.5 billion. The company’s share price, although this year has risen by 8%, 13.2% has fallen since it was mentioned as a listed company in May 2022.
Third point strives for different strategies, including from time to time, activism in which it deals with management to push companies, including Advance Auto Parts, Walt Disney and Bath & Body works to perform better.
It supervises around $ 12 billion in assets and returned 25% in 2024, a dramatic increase in a profit of around 4% in 2023 and a loss of 22% in 2022. Last year the company turned into consumer-discretionary, financial and industrial companies that helped with the return after a post-election rally.
(Reporting by Svea Herbst-Bayliss; Additional reporting by Sriparna Roy in Bangalore; Edit by Will Dunham)
